 Girish Shirali
Concepts (360)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 35 | 2020 | 80 | 6.600 |
Why?
| | Echocardiography | 37 | 2022 | 81 | 5.140 |
Why?
| | Echocardiography, Three-Dimensional | 24 | 2018 | 26 | 4.670 |
Why?
| | Heart Ventricles | 22 | 2023 | 49 | 4.030 |
Why?
| | Cardiac Catheterization | 17 | 2024 | 20 | 2.290 |
Why?
| | Pulmonary Valve Insufficiency | 8 | 2024 | 8 | 2.290 |
Why?
| | Ventricular Dysfunction, Left | 12 | 2017 | 19 | 2.160 |
Why?
| | Humans | 105 | 2024 | 6915 | 2.030 |
Why?
| | Pulmonary Valve | 8 | 2024 | 8 | 1.860 |
Why?
| | Ventricular Function, Left | 13 | 2019 | 28 | 1.620 |
Why?
| | Heart Valve Prosthesis Implantation | 8 | 2024 | 8 | 1.620 |
Why?
| | Fontan Procedure | 9 | 2022 | 19 | 1.570 |
Why?
| | Cardiac Surgical Procedures | 13 | 2016 | 29 | 1.540 |
Why?
| | Heart Transplantation | 10 | 2017 | 14 | 1.530 |
Why?
| | Pediatrics | 9 | 2016 | 185 | 1.460 |
Why?
| | Heart Valve Prosthesis | 7 | 2024 | 7 | 1.450 |
Why?
| | Infant | 40 | 2023 | 1464 | 1.430 |
Why?
| | Heart Failure | 5 | 2022 | 14 | 1.410 |
Why?
| | Female | 55 | 2024 | 3563 | 1.380 |
Why?
| | Male | 49 | 2024 | 3383 | 1.300 |
Why?
| | Echocardiography, Doppler, Color | 5 | 2016 | 5 | 1.260 |
Why?
| | Image Interpretation, Computer-Assisted | 6 | 2018 | 21 | 1.170 |
Why?
| | Aortic Rupture | 2 | 2016 | 2 | 1.120 |
Why?
| | Practice Guidelines as Topic | 3 | 2016 | 108 | 1.110 |
Why?
| | Aorta, Thoracic | 5 | 2016 | 9 | 1.080 |
Why?
| | Stroke Volume | 12 | 2018 | 19 | 1.060 |
Why?
| | Child, Preschool | 36 | 2018 | 1600 | 1.040 |
Why?
| | Child | 44 | 2022 | 3393 | 1.030 |
Why?
| | Adolescent | 39 | 2024 | 2235 | 1.010 |
Why?
| | Infant, Newborn | 29 | 2021 | 825 | 1.010 |
Why?
| | Adult | 21 | 2024 | 1187 | 0.970 |
Why?
| | Treatment Outcome | 21 | 2024 | 624 | 0.960 |
Why?
| | Heart Diseases | 7 | 2022 | 19 | 0.950 |
Why?
| | Heart Septal Defects, Atrial | 4 | 2006 | 5 | 0.950 |
Why?
| | Hypoplastic Left Heart Syndrome | 9 | 2020 | 19 | 0.950 |
Why?
| | Cardiomyopathies | 3 | 2015 | 6 | 0.840 |
Why?
| | Aortic Coarctation | 3 | 2016 | 5 | 0.780 |
Why?
| | Echocardiography, Transesophageal | 6 | 2012 | 7 | 0.770 |
Why?
| | Reproducibility of Results | 18 | 2021 | 201 | 0.760 |
Why?
| | Heart | 4 | 2016 | 14 | 0.740 |
Why?
| | Ventricular Function, Right | 3 | 2016 | 9 | 0.730 |
Why?
| | Image Enhancement | 3 | 2016 | 13 | 0.720 |
Why?
| | Pulmonary Artery | 8 | 2013 | 10 | 0.710 |
Why?
| | Ultrasonography, Prenatal | 5 | 2015 | 9 | 0.710 |
Why?
| | Cardiac Imaging Techniques | 2 | 2016 | 2 | 0.680 |
Why?
| | Cardiology | 7 | 2015 | 10 | 0.670 |
Why?
| | Prospective Studies | 17 | 2024 | 532 | 0.640 |
Why?
| | Aortic Stenosis, Supravalvular | 2 | 2016 | 2 | 0.630 |
Why?
| | United States | 15 | 2024 | 685 | 0.620 |
Why?
| | Exercise | 2 | 2020 | 138 | 0.610 |
Why?
| | Sensitivity and Specificity | 12 | 2016 | 149 | 0.590 |
Why?
| | Follow-Up Studies | 17 | 2019 | 302 | 0.590 |
Why?
| | Patient Care Team | 2 | 2020 | 18 | 0.570 |
Why?
| | Aortic Aneurysm | 1 | 2016 | 1 | 0.560 |
Why?
| | Sinus of Valsalva | 1 | 2016 | 2 | 0.560 |
Why?
| | Cardiology Service, Hospital | 1 | 2016 | 3 | 0.540 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2016 | 7 | 0.540 |
Why?
| | Young Adult | 12 | 2024 | 657 | 0.510 |
Why?
| | Heart Septal Defects, Ventricular | 4 | 2011 | 4 | 0.510 |
Why?
| | Prosthesis Design | 5 | 2024 | 8 | 0.490 |
Why?
| | Telemedicine | 1 | 2016 | 56 | 0.480 |
Why?
| | Risk Factors | 15 | 2024 | 485 | 0.480 |
Why?
| | Prognosis | 8 | 2021 | 212 | 0.460 |
Why?
| | Cardiomyopathy, Dilated | 4 | 2015 | 9 | 0.450 |
Why?
| | Echocardiography, Doppler | 7 | 2019 | 11 | 0.430 |
Why?
| | Magnetic Resonance Imaging | 6 | 2016 | 122 | 0.430 |
Why?
| | Retrospective Studies | 14 | 2023 | 1300 | 0.430 |
Why?
| | Palliative Care | 4 | 2020 | 15 | 0.410 |
Why?
| | Recovery of Function | 3 | 2024 | 17 | 0.410 |
Why?
| | Societies, Medical | 4 | 2016 | 51 | 0.400 |
Why?
| | Europe | 6 | 2024 | 37 | 0.400 |
Why?
| | Time Factors | 8 | 2024 | 238 | 0.400 |
Why?
| | Fetal Diseases | 2 | 2004 | 9 | 0.400 |
Why?
| | Aortic Diseases | 2 | 2013 | 4 | 0.390 |
Why?
| | Postoperative Complications | 6 | 2018 | 187 | 0.390 |
Why?
| | Ventricular Pressure | 3 | 2019 | 3 | 0.380 |
Why?
| | Graft Rejection | 4 | 2015 | 32 | 0.370 |
Why?
| | Monitoring, Physiologic | 3 | 2020 | 22 | 0.370 |
Why?
| | Diastole | 7 | 2019 | 11 | 0.360 |
Why?
| | Predictive Value of Tests | 5 | 2021 | 100 | 0.350 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 9 | 0.350 |
Why?
| | Feasibility Studies | 7 | 2020 | 57 | 0.350 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2009 | 4 | 0.340 |
Why?
| | Vascular Malformations | 1 | 2009 | 3 | 0.340 |
Why?
| | Angiography | 1 | 2009 | 8 | 0.340 |
Why?
| | Ventricular Function | 2 | 2022 | 5 | 0.310 |
Why?
| | Ventricular Fibrillation | 1 | 2007 | 1 | 0.300 |
Why?
| | Ventricular Outflow Obstruction | 3 | 2018 | 3 | 0.290 |
Why?
| | Transposition of Great Vessels | 3 | 2011 | 7 | 0.280 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 10 | 0.280 |
Why?
| | Abnormalities, Multiple | 2 | 2008 | 36 | 0.270 |
Why?
| | Balloon Occlusion | 1 | 2005 | 1 | 0.260 |
Why?
| | Norwood Procedures | 3 | 2020 | 4 | 0.260 |
Why?
| | Stroke | 1 | 2005 | 21 | 0.260 |
Why?
| | Systole | 4 | 2015 | 10 | 0.260 |
Why?
| | Heart Atria | 2 | 2005 | 2 | 0.250 |
Why?
| | Survival Rate | 5 | 2007 | 83 | 0.240 |
Why?
| | Internship and Residency | 2 | 2015 | 39 | 0.240 |
Why?
| | Middle Aged | 5 | 2024 | 614 | 0.230 |
Why?
| | Myocardium | 2 | 2015 | 12 | 0.230 |
Why?
| | Oxygen Consumption | 2 | 2022 | 18 | 0.230 |
Why?
| | Equipment Failure Analysis | 2 | 2014 | 4 | 0.230 |
Why?
| | Radiology, Interventional | 1 | 2003 | 1 | 0.220 |
Why?
| | Algorithms | 3 | 2015 | 103 | 0.220 |
Why?
| | Equipment Design | 4 | 2014 | 14 | 0.220 |
Why?
| | Ultrasonography | 4 | 2013 | 47 | 0.220 |
Why?
| | Myocardial Contraction | 3 | 2018 | 7 | 0.210 |
Why?
| | Embolization, Therapeutic | 1 | 2002 | 12 | 0.200 |
Why?
| | Pregnancy | 6 | 2009 | 214 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2013 | 48 | 0.200 |
Why?
| | Coronary Artery Disease | 3 | 2011 | 10 | 0.200 |
Why?
| | Oxygen | 2 | 2020 | 14 | 0.200 |
Why?
| | Telemetry | 1 | 2021 | 2 | 0.190 |
Why?
| | Remote Consultation | 1 | 2021 | 4 | 0.190 |
Why?
| | Patient Admission | 1 | 2021 | 9 | 0.190 |
Why?
| | Genome, Viral | 1 | 2001 | 4 | 0.190 |
Why?
| | Adenoviridae Infections | 1 | 2001 | 3 | 0.190 |
Why?
| | Video Recording | 1 | 2021 | 14 | 0.190 |
Why?
| | Adenoviridae | 1 | 2001 | 6 | 0.190 |
Why?
| | Aortic Valve | 3 | 2016 | 3 | 0.190 |
Why?
| | Observer Variation | 5 | 2016 | 16 | 0.190 |
Why?
| | Coronary Vessels | 2 | 2011 | 3 | 0.190 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2011 | 9 | 0.190 |
Why?
| | Ductus Arteriosus, Patent | 2 | 2006 | 4 | 0.180 |
Why?
| | Heart Aneurysm | 1 | 2000 | 1 | 0.180 |
Why?
| | Home Nursing | 1 | 2020 | 1 | 0.180 |
Why?
| | Weight Gain | 1 | 2020 | 22 | 0.180 |
Why?
| | Quality Improvement | 2 | 2020 | 60 | 0.170 |
Why?
| | Caregivers | 2 | 2020 | 41 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2020 | 61 | 0.170 |
Why?
| | Enalapril | 1 | 2019 | 1 | 0.170 |
Why?
| | Dilatation, Pathologic | 2 | 2016 | 6 | 0.160 |
Why?
| | Mitral Valve | 3 | 2007 | 4 | 0.160 |
Why?
| | Marfan Syndrome | 2 | 2013 | 2 | 0.160 |
Why?
| | Incidence | 6 | 2016 | 134 | 0.160 |
Why?
| | Home Care Services | 1 | 2018 | 6 | 0.150 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 16 | 0.150 |
Why?
| | Medical Records | 1 | 2018 | 14 | 0.150 |
Why?
| | Pulmonary Veins | 1 | 1998 | 1 | 0.150 |
Why?
| | Cross-Over Studies | 1 | 2018 | 36 | 0.150 |
Why?
| | Transplant Recipients | 1 | 2017 | 9 | 0.150 |
Why?
| | Exercise Test | 2 | 2015 | 17 | 0.150 |
Why?
| | Expert Testimony | 1 | 2016 | 2 | 0.140 |
Why?
| | Vascular Stiffness | 1 | 2016 | 5 | 0.140 |
Why?
| | Patient Care Bundles | 1 | 2016 | 3 | 0.140 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 48 | 0.140 |
Why?
| | Consensus | 1 | 2016 | 35 | 0.140 |
Why?
| | Remote Sensing Technology | 1 | 2016 | 3 | 0.130 |
Why?
| | Cloud Computing | 1 | 2016 | 4 | 0.130 |
Why?
| | Anastomosis, Surgical | 4 | 2012 | 21 | 0.130 |
Why?
| | Postoperative Care | 1 | 2016 | 30 | 0.130 |
Why?
| | Diffusion of Innovation | 1 | 2016 | 7 | 0.130 |
Why?
| | Models, Organizational | 1 | 2016 | 7 | 0.130 |
Why?
| | Attitude to Computers | 1 | 2016 | 4 | 0.130 |
Why?
| | Computers, Handheld | 1 | 2016 | 8 | 0.130 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 14 | 0.130 |
Why?
| | Program Evaluation | 1 | 2016 | 45 | 0.130 |
Why?
| | Clinical Competence | 3 | 2015 | 28 | 0.130 |
Why?
| | Education, Medical, Continuing | 1 | 2015 | 6 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 67 | 0.130 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 5 | 0.130 |
Why?
| | Multivariate Analysis | 4 | 2009 | 71 | 0.130 |
Why?
| | Aged | 3 | 2009 | 382 | 0.130 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2015 | 1 | 0.120 |
Why?
| | Advisory Committees | 1 | 2015 | 9 | 0.120 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2016 | 3 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 16 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 17 | 0.120 |
Why?
| | Biomarkers | 2 | 2016 | 133 | 0.120 |
Why?
| | Internationality | 1 | 2014 | 6 | 0.120 |
Why?
| | Elasticity Imaging Techniques | 1 | 2014 | 7 | 0.120 |
Why?
| | Neoplasms | 1 | 2016 | 128 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2020 | 216 | 0.120 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2014 | 6 | 0.120 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2005 | 151 | 0.110 |
Why?
| | Ultrasonography, Interventional | 2 | 2013 | 5 | 0.110 |
Why?
| | Severity of Illness Index | 3 | 2015 | 153 | 0.110 |
Why?
| | Biopsy | 2 | 2006 | 61 | 0.110 |
Why?
| | Ultrasonic Therapy | 1 | 2013 | 1 | 0.110 |
Why?
| | Cardiac Catheters | 1 | 2013 | 1 | 0.110 |
Why?
| | Body Mass Index | 1 | 2014 | 157 | 0.110 |
Why?
| | Obesity | 1 | 2014 | 117 | 0.110 |
Why?
| | Organ Size | 4 | 2012 | 14 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 77 | 0.100 |
Why?
| | South Carolina | 3 | 2014 | 3 | 0.100 |
Why?
| | Data Display | 1 | 2012 | 1 | 0.100 |
Why?
| | Heart Valves | 1 | 2012 | 1 | 0.100 |
Why?
| | Bioprosthesis | 1 | 2011 | 1 | 0.100 |
Why?
| | Echocardiography, Doppler, Pulsed | 1 | 2011 | 1 | 0.100 |
Why?
| | Risk Assessment | 3 | 2021 | 136 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 33 | 0.090 |
Why?
| | Mitral Valve Insufficiency | 1 | 2011 | 1 | 0.090 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2011 | 1 | 0.090 |
Why?
| | Exercise Tolerance | 1 | 2010 | 8 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 339 | 0.090 |
Why?
| | Miniaturization | 1 | 2010 | 2 | 0.090 |
Why?
| | Treatment Failure | 2 | 2011 | 18 | 0.090 |
Why?
| | Quality of Life | 2 | 2022 | 143 | 0.090 |
Why?
| | Coronary Disease | 2 | 2001 | 5 | 0.090 |
Why?
| | Septal Occluder Device | 1 | 2009 | 2 | 0.090 |
Why?
| | Stents | 1 | 2009 | 3 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2009 | 5 | 0.090 |
Why?
| | Chromosome Aberrations | 1 | 2009 | 12 | 0.080 |
Why?
| | Vitamin A | 1 | 1989 | 3 | 0.080 |
Why?
| | Cardiac Volume | 1 | 2009 | 1 | 0.080 |
Why?
| | Decision Making | 1 | 2009 | 23 | 0.080 |
Why?
| | Heart Septum | 2 | 2006 | 2 | 0.080 |
Why?
| | Intensive Care Units | 1 | 2009 | 16 | 0.080 |
Why?
| | Heart Valve Diseases | 2 | 2007 | 2 | 0.080 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2008 | 3 | 0.080 |
Why?
| | Mass Screening | 1 | 2008 | 35 | 0.080 |
Why?
| | Reoperation | 3 | 2020 | 61 | 0.080 |
Why?
| | Comorbidity | 3 | 2014 | 56 | 0.080 |
Why?
| | Hemodynamics | 2 | 2024 | 10 | 0.080 |
Why?
| | Disease Progression | 2 | 2021 | 111 | 0.070 |
Why?
| | Parents | 1 | 2009 | 160 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2007 | 18 | 0.070 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2007 | 1 | 0.070 |
Why?
| | Heart Bypass, Right | 1 | 2007 | 3 | 0.070 |
Why?
| | Prenatal Diagnosis | 2 | 2005 | 14 | 0.070 |
Why?
| | Preoperative Care | 1 | 2007 | 26 | 0.070 |
Why?
| | Communication | 2 | 2020 | 46 | 0.070 |
Why?
| | Heart Septal Defects | 1 | 2006 | 1 | 0.070 |
Why?
| | Research Design | 1 | 2006 | 63 | 0.070 |
Why?
| | Pilot Projects | 2 | 2017 | 118 | 0.070 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2006 | 2 | 0.070 |
Why?
| | Heart Arrest | 1 | 2006 | 3 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 88 | 0.060 |
Why?
| | Regression Analysis | 2 | 2015 | 52 | 0.060 |
Why?
| | Medical Illustration | 1 | 2004 | 1 | 0.060 |
Why?
| | Balloon Valvuloplasty | 1 | 2024 | 1 | 0.060 |
Why?
| | Congresses as Topic | 2 | 2015 | 9 | 0.060 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2004 | 3 | 0.060 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2004 | 3 | 0.060 |
Why?
| | Trisomy | 1 | 2004 | 2 | 0.060 |
Why?
| | Pregnancy Outcome | 1 | 2004 | 6 | 0.060 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 52 | 0.060 |
Why?
| | Empathy | 1 | 2023 | 2 | 0.050 |
Why?
| | Hand Strength | 1 | 2022 | 7 | 0.050 |
Why?
| | Fatigue | 1 | 2022 | 15 | 0.050 |
Why?
| | Prevalence | 2 | 2014 | 150 | 0.050 |
Why?
| | Equipment Safety | 1 | 2002 | 1 | 0.050 |
Why?
| | Device Removal | 1 | 2002 | 14 | 0.050 |
Why?
| | Pulmonary Circulation | 1 | 2002 | 1 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2002 | 18 | 0.050 |
Why?
| | Patient Selection | 1 | 2002 | 39 | 0.050 |
Why?
| | Pulmonary Atresia | 1 | 2001 | 1 | 0.050 |
Why?
| | Educational Measurement | 2 | 2015 | 5 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2001 | 6 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2001 | 3 | 0.050 |
Why?
| | Safety | 2 | 1998 | 14 | 0.050 |
Why?
| | Forecasting | 2 | 1998 | 20 | 0.050 |
Why?
| | Curriculum | 2 | 2015 | 23 | 0.050 |
Why?
| | Health Status | 1 | 2021 | 25 | 0.050 |
Why?
| | Logistic Models | 2 | 2013 | 85 | 0.050 |
Why?
| | Virus Diseases | 1 | 2001 | 16 | 0.050 |
Why?
| | Hypertension | 2 | 1998 | 66 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2001 | 83 | 0.050 |
Why?
| | Checklist | 1 | 2020 | 3 | 0.050 |
Why?
| | Transitional Care | 1 | 2020 | 3 | 0.050 |
Why?
| | American Heart Association | 1 | 2020 | 3 | 0.050 |
Why?
| | Oximetry | 1 | 2020 | 8 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2020 | 7 | 0.040 |
Why?
| | Accelerometry | 1 | 2020 | 47 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 1 | 2000 | 30 | 0.040 |
Why?
| | Patient Discharge | 1 | 2020 | 57 | 0.040 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 13 | 0.040 |
Why?
| | Graft Survival | 2 | 1998 | 32 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2019 | 45 | 0.040 |
Why?
| | Phenotype | 1 | 2020 | 260 | 0.040 |
Why?
| | Registries | 2 | 2013 | 95 | 0.040 |
Why?
| | Compassionate Use Trials | 1 | 2018 | 1 | 0.040 |
Why?
| | Angioplasty, Balloon | 1 | 1998 | 1 | 0.040 |
Why?
| | Dobutamine | 1 | 1998 | 1 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 5 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 1998 | 45 | 0.040 |
Why?
| | Linear Models | 1 | 1998 | 56 | 0.040 |
Why?
| | Hospitals, University | 1 | 2018 | 3 | 0.040 |
Why?
| | Videotape Recording | 1 | 1998 | 3 | 0.040 |
Why?
| | Recurrence | 1 | 1998 | 113 | 0.040 |
Why?
| | Pericardium | 1 | 1997 | 5 | 0.040 |
Why?
| | Cohort Studies | 1 | 2018 | 288 | 0.040 |
Why?
| | Troponin I | 1 | 2016 | 3 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2016 | 12 | 0.040 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2016 | 6 | 0.040 |
Why?
| | Boston | 1 | 2016 | 1 | 0.030 |
Why?
| | Survivors | 1 | 2016 | 18 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 4 | 0.030 |
Why?
| | Manometry | 1 | 2016 | 3 | 0.030 |
Why?
| | Sodium Chloride | 1 | 2016 | 3 | 0.030 |
Why?
| | Causality | 1 | 2016 | 10 | 0.030 |
Why?
| | Reference Standards | 1 | 2016 | 15 | 0.030 |
Why?
| | North America | 1 | 2016 | 44 | 0.030 |
Why?
| | Missouri | 1 | 2016 | 80 | 0.030 |
Why?
| | Life Tables | 1 | 1995 | 2 | 0.030 |
Why?
| | Survival Analysis | 2 | 2007 | 50 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 16 | 0.030 |
Why?
| | Reference Values | 1 | 2015 | 39 | 0.030 |
Why?
| | Fetal Heart | 1 | 2015 | 2 | 0.030 |
Why?
| | Down Syndrome | 1 | 1995 | 39 | 0.030 |
Why?
| | Competency-Based Education | 1 | 2015 | 5 | 0.030 |
Why?
| | Teaching | 1 | 2015 | 2 | 0.030 |
Why?
| | Goals | 1 | 2015 | 6 | 0.030 |
Why?
| | Embryonic and Fetal Development | 1 | 1994 | 5 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 22 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 188 | 0.030 |
Why?
| | Atenolol | 1 | 2013 | 1 | 0.030 |
Why?
| | Losartan | 1 | 2013 | 1 | 0.030 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 1 | 0.030 |
Why?
| | Technology Assessment, Biomedical | 1 | 2013 | 1 | 0.030 |
Why?
| | Bioengineering | 1 | 2013 | 1 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 6 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2013 | 4 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2013 | 22 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2013 | 5 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2013 | 11 | 0.030 |
Why?
| | Thrombolytic Therapy | 1 | 2013 | 8 | 0.030 |
Why?
| | Research | 1 | 2013 | 13 | 0.030 |
Why?
| | Software | 1 | 2013 | 29 | 0.030 |
Why?
| | Blalock-Taussig Procedure | 1 | 2012 | 1 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2011 | 6 | 0.020 |
Why?
| | Transplantation, Homologous | 2 | 2004 | 19 | 0.020 |
Why?
| | Postoperative Period | 1 | 2010 | 18 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2011 | 32 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 82 | 0.020 |
Why?
| | Infant, Low Birth Weight | 1 | 2010 | 14 | 0.020 |
Why?
| | Amniocentesis | 1 | 2009 | 1 | 0.020 |
Why?
| | Maternal Age | 1 | 2009 | 2 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 12 | 0.020 |
Why?
| | Retinol-Binding Proteins | 1 | 1989 | 1 | 0.020 |
Why?
| | Vitamin A Deficiency | 1 | 1989 | 1 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 51 | 0.020 |
Why?
| | Fetal Blood | 1 | 1989 | 5 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 1 | 1989 | 6 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2008 | 1 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2008 | 5 | 0.020 |
Why?
| | Tachycardia | 1 | 2008 | 3 | 0.020 |
Why?
| | Monitoring, Intraoperative | 1 | 2007 | 2 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2007 | 5 | 0.020 |
Why?
| | Models, Statistical | 1 | 2007 | 30 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2005 | 1 | 0.020 |
Why?
| | Vascular Resistance | 1 | 2005 | 4 | 0.020 |
Why?
| | Aortic Valve Stenosis | 1 | 2005 | 2 | 0.020 |
Why?
| | Fetus | 1 | 2005 | 16 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2005 | 70 | 0.020 |
Why?
| | Blood Gas Analysis | 1 | 2004 | 6 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2004 | 17 | 0.010 |
Why?
| | Canada | 1 | 2004 | 33 | 0.010 |
Why?
| | Animals | 1 | 2005 | 657 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2001 | 19 | 0.010 |
Why?
| | Magnetic Resonance Angiography | 1 | 2001 | 9 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2001 | 20 | 0.010 |
Why?
| | Infant, Premature | 1 | 2001 | 84 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 1998 | 1 | 0.010 |
Why?
| | Coronary Angiography | 1 | 1998 | 2 | 0.010 |
Why?
| | Cause of Death | 1 | 1998 | 13 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1997 | 3 | 0.010 |
Why?
| | Surgical Flaps | 1 | 1997 | 6 | 0.010 |
Why?
| | Cryopreservation | 1 | 1996 | 5 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|